RYRui Yang

Rui Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rui Yang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of F11 Gene Variants With Cardiovascular Events and Cardiac Function

    by Qianxi Ye, Shengtao Hu, Rui Yang, Yilin Lai, Zhang Chen, Jiajun Li, Haige Zhao, Jiayuan Wu, Liang Ma, Zhijun Dai

    Background: FXI (Factor XI) inhibitors have emerged as a promising antithrombotic strategy. However, a recent study linked decreased FXI levels with increased risk of heart failure (HF) and atrial fibrillation (AF), particularly in older adults. This study aims to investigate the associations of genetic FXI inhibition with cardiovascular events and cardiac function. Methods: This prospective study included 408 642 UK Biobank participants of European ancestry. Two F11 ‐based genetic scores were constructed, weighted separately by their associations with activated partial thromboplastin time or circulating FXI levels. Adjusted Cox or linear regression models were built to predict incident HF, AF, and cardiac magnetic resonance measures. Interactions with age and age‐related cardiometabolic traits were tested. Results: Over 14.6 years median follow‐up, 14 451 participants developed incident HF, and 29 243 developed incident AF. The FXI activated partial thromboplastin time score was not associated with HF, AF, or cardiac magnetic resonance measures overall. In exploratory interaction analyses, baseline hemoglobin A1c (HbA1c) modified its association with HF ( P P =0.027), with higher HF risk observed among participants with HbA1c≥7% (hazard ratio per 10% genetically predicted increase in activated partial thromboplastin time, 1.65 [95% CI, 1.13–2.40]) but not in those with HbA1c<7%. No association was observed with AF across HbA1c strata. Similar patterns were observed for the FXI level score. Conclusions: Genetically proxied FXI inhibition was not associated with HF, AF, or cardiac magnetic resonance–derived cardiac measures overall, but its associations with HF and AF may be modified by HbA1c. Future studies are needed to verify these exploratory findings.

  • Open Access

    Relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis

    by Qing Wu, Liwen Shen, Shengtao Hu, Rui Yang, Yingnan Wang, Dixuan Xue, Yuchen Sun, Haiyan Ma, Zhijun Dai

    Menopausal hormone therapy (MHT) is widely prescribed for alleviating menopausal symptoms. Prior studies have mainly focused on individual hormone therapy formulations. This meta-analysis comprehensively synthesized evidence across various regimens to systematically evaluate the association between MHT and breast cancer risk. We systematically searched CNKI, Wanfang, PubMed, and Web of Science from inception through August 2024. Eligible studies examining breast cancer risk following MHT were independently screened and assessed by two reviewers. The review and meta-analysis followed PRISMA guidelines. Thirty-four studies were included. The random-effects model showed a significant but heterogeneous overall association (OR = 1.15, 95% CI: 1.09-1.22; I² = 92.4%). Subgroup analysis identified hormone type, use status, and region as key determinants (P for interaction < 0.001). Stratification by hormone type resolved much of the heterogeneity, revealing risk confined to estrogen-progestin therapy (EPT; OR = 1.44, 95% CI: 1.26-1.64), while estrogen-only therapy (ET) showed no overall association (OR = 1.00, 95% CI: 0.91-1.10). Study type, region, and sample size were significant effect modifiers. For ET, randomized controlled trials demonstrated a protective effect (OR = 0.78, 95% CI: 0.70-0.87), contrasting with neutral findings from observational studies. MHT is associated with a modest but significant increase in breast cancer risk, primarily driven by EPT. This risk was not observed with ET in observational studies, though trials suggested a protective effect. Crucially, the association shows marked geographical heterogeneity, indicating risk is modified by regimen and regional factors.


  • Open Access

    Risk factors and an interpretability tool of in-hospital mortality in critically ill patients with acute myocardial infarction

    by Rui Yang, Tao Huang, Renqi Yao, Di Wang, Yang Hu, Longbing Ren, Shaojie Li, Yali Zhao, Zhijun Dai


  • Open Access

    Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease

    by Shiqi Yuan, Chong Chen, Fengshuo Xu, Didi Han, Rui Yang, Shuai Zheng, Mengmeng Qiao, Xiaxuan Huang, Jun Lyu

    Objective. The effectiveness of antithrombotic drugs for treating sepsis is controversial. Here, we explore the association between antithrombotic therapy and intensive care unit (ICU) mortality for septic patients with peripheral vascular disease. Methods. This retrospective cohort study uses data from the Medical Information Mart for Intensive Care (MIMIC)‐III database. Kaplan–Meier survival analyses were used to examine mortality among different groups. Cox regression and marginal structural Cox models (MSCMs) were used to adjust for confounding factors. Main Results. The final cohort from the MIMIC‐III database included 776 patients, of which 701 survived and 75 perished. The anticoagulant (AC) group and the antiplatelet‐anticoagulation (AC‐AP) group survived better than the group without antithrombotic treatment (non‐AT). The AC and AC‐AP groups showed a 0.363‐fold and 0.373‐fold risk of ICU mortality, respectively, compared with the non‐AT group when controlling for age, gender, CRRT, alcohol, heart failure, hypertension, diabetes, obesity, renal failure, liver disease, INR, PT, PPT, and SpO2. Antiplatelet therapy did not reduce ICU mortality. The same trends were apparent from the MSCM. In addition, the AC‐AP group exhibited a lower risk of bleeding complications. Conclusion. Although the antithrombotic group (AC and AC‐AP groups) demonstrated a higher sequential organ failure assessment (SOFA) score than the group without antithrombotic treatment (non‐AT group), the risk of ICU mortality was lower without increasing the risk of bleeding complications. Our study further suggested that anticoagulation therapy may benefit the prognosis of septic patients with peripheral vascular disease.


  • Open Access

    Deep-Learning-Based Survival Prediction of Patients in Coronary Care Units

    by Rui Yang, Tao Huang, Zichen Wang, Wei Huang, Aozi Feng, Li Li, Jun Lyu

    Background. A survival prediction model based on deep learning has higher accuracy than the CPH model in predicting the survival of CCU patients, and it also has a better discrimination ability. We collected information on patients with various diseases in coronary care units (CCUs) from the Medical Information Mart for Intensive Care III (MIMIC-III) database. The purpose of this study was to use this information to construct a neural-network model based on deep learning to predict the survival probabilities of patients with conditions that are common in CCUs. Method. We collected information on patients in the United States with five common diseases in CCUs from 2001 to 2012. We randomly divided the patients into a training cohort and a testing cohort at a ratio of 7 : 3 and applied a survival prediction method based on deep learning to predict their survival probability. We compared our model with the Cox proportional-hazards regression (CPH) model and used the concordance indexes (C-indexes), receiver operating characteristic (ROC) curve, and calibration plots to evaluate the predictive performance of the model. Results. The 3,388 CCU patients included in the study were randomly divided into 2,371 in the training cohort and 1,017 in the testing cohort. The stepwise regression results showed that the important factors affecting patient survival were the type of disease, age, race, anion gap, glucose, neutrophils, white blood cells, potassium, creatine kinase, and blood urea nitrogen ( ). We used the training cohort to construct a deep-learning model, for which the C-index was 0.833, or about 5% higher than that for the CPH model (0.786). The C-index of the deep-learning model for the test cohort was 0.822, which was also higher than that for the CPH model (0.782). The areas under the ROC curve for the 28-day, 90-day, and 1-year survival probabilities were 0.875, 0.865, and 0.874, respectively, in the deep-learning model, respectively, and 0.830, 0.843, and 0.806 in the CPH model. These values indicate that the survival analysis model based on deep learning is better than the traditional CPH model in predicting the survival of CCU patients. Conclusion. A survival prediction model based on deep learning has higher accuracy than the CPH model in predicting the survival of CCU patients, and it also has a better discrimination ability.


  • Open Access

    Obesity Paradox of All-Cause Mortality in 4,133 Patients Treated with Coronary Revascularization

    by Chengzhuo Li, Didi Han, Fengshuo Xu, Shuai Zheng, Luming Zhang, Zichen Wang, Rui Yang, Haiyan Yin, Jun Lyu

    Objectives. The purpose of this study was to determine whether there is a dose-response relationship between body mass index (BMI) and all-cause mortality in patients after coronary revascularization. Methods. The MIMIC-III database (version 1.4) was used as the sample population. For variables with less than 10% of values missing, we used the mice package of R software for multiple imputations. Cox regression was used to determine the risk factors of all-cause mortality in patients. RCSs were used to observe the relationship between BMI and all-cause mortality. Additional subgroup and sensitivity analyses were also performed to explore whether the conclusion can be applied to specific groups. Results. Both univariate and multivariate Cox models indicated that the mortality risk was lower for overweight patients than for normal-weight patients ( ). In RCS models, BMI had a U-shaped relationship with all-cause mortality of patients after coronary artery bypass grafting (CABG) ( for nonlinearity = 0.0028). There was a weak U-shaped relationship between BMI and all-cause mortality after percutaneous coronary intervention (PCI), but the nonlinear relationship between these two parameters was not significant ( for nonlinearity = 0.1756). Conclusions. The obesity paradox does exist in patients treated with CABG and PCI. RCS analysis indicated that there was a U-shaped relationship between BMI and all-cause mortality in patients after CABG. After sex stratification, the relationship between BMI and all-cause mortality in male patients who received PCI was L-shaped, while the nonlinear relationship among females was not significant.


  • Open Access

    A Novel Nomogram for Predicting Survival in Patients with Severe Acute Pancreatitis: An Analysis Based on the Large MIMIC-III Clinical Database

    by Didi Han, Fengshuo Xu, Chengzhuo Li, Luming Zhang, Rui Yang, Shuai Zheng, Zichen Wang, Jun Lyu

    Background. Severe acute pancreatitis (SAP) can cause various complications. Septic shock is a relatively common and serious complication that causes uncontrolled systemic inflammatory response syndrome, which is one of the main causes of death. This study aimed to develop a nomogram for predicting the overall survival of SAP patients during the initial 24 hours following admission. Materials and Methods. All the data utilized in this study were obtained from the MIMIC-III (Medical Information Mart for Intensive Care III) database. The data were analyzed using multivariate Cox regression, and the performance of the proposed nomogram was evaluated based on Harrells concordance index (C-index) and the area under the receiver operating characteristic curve (AUC). The clinical value of the prediction model was tested using decision-curve analysis (DCA). The primary outcomes were 28-day, 60-day, and 90-day mortality rates. Results. The 850 patients included in the analysis comprised 595 in the training cohort and 255 in the validation cohort. The training cohort consisted of 353 (59.3) males and 242 (40.7) females with SAP. Multivariate Cox regression showed that weight, sex, insurance status, explicit sepsis, SAPSII score, Elixhauser score, bilirubin, anion gap, creatinine, hematocrit, hemoglobin, RDW, SPO2, and respiratory rate were independent prognostic factors for the survival of SAP patients admitted to an intensive care unit. The predicted values were compared using C-indexes, calibration plots, integrated discrimination improvement, net reclassification improvement, and DCA. Conclusions. We have identified some important demographic and laboratory parameters related to the prognosis of patients with SAP and have used them to establish a more accurate and convenient nomogram for evaluating their 28-day, 60-day, and 90-day mortality rates.


  • Open Access

    Prognostic Value of Blood Urea Nitrogen/Creatinine Ratio for Septic Shock: An Analysis of the MIMIC‐III Clinical Database

    by Didi Han, Luming Zhang, Shuai Zheng, Fengshuo Xu, Chengzhuo Li, Rui Yang, Wen Ma, Haiyan Yin, Jun Lyu

    Background. Research has previously been done into the risk factors for mortality in septic shock patients. However, there has been no epidemiological study investigating the effect of the blood urea nitrogen/creatinine ratio (BCR) on the prognosis of critically ill septic shock patients. This study is aimed at determining the relationship between BCR and all‐cause mortality in adult septic shock patients. Methods. Data were extracted from the MIMIC‐III database. The clinical endpoints were 28‐, 90‐, and 365‐day all‐cause mortality rates in critically ill septic shock patients. Cox proportional hazards models and subgroup analyses were used to analyze the relationship between BCR quartiles and all‐cause mortality in septic shock patients. Receiver operator characteristic (ROC) curves and areas under the ROC curves (AUCs) were calculated to evaluate how accurately BCR predicts the mortality of septic shock patients. Results. Among the 2484 septic shock patients extracted from the database, 619, 563, 677, and 625 fell into the first (P < 0.001). In the Cox regression model adjusted for different confounding variables, BCR values in the fourth quartiles were significantly associated with increased mortality, using the first quartiles as a reference. The areas under the ROC curves (AUCs) for BCR plus the Sequential Organ Failure Assessment (SOFA) score and BCR plus Acute Physiology Score III (APSIII) were 0.694 (95% CI: 0.673‐0.716) and 0.724 (95% CI: 0.703‐0.744), respectively. Conclusion. An inverse M‐shaped curve was determined between BCR and the mortality of septic shock patients. BCR was identified as a readily available and independent prognostic biomarker for septic shock patients, and higher BCRs were associated with increased mortality in these patients.